These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 26541795)

  • 1. Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients.
    Bergsland N; Zivadinov R; Dwyer MG; Weinstock-Guttman B; Benedict RH
    Mult Scler; 2016 Sep; 22(10):1327-36. PubMed ID: 26541795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis.
    Kim G; Chu R; Yousuf F; Tauhid S; Stazzone L; Houtchens MK; Stankiewicz JM; Severson C; Kimbrough D; Quintana FJ; Chitnis T; Weiner HL; Healy BC; Bakshi R
    Int J Neurosci; 2017 Nov; 127(11):971-980. PubMed ID: 28100092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume.
    Bisecco A; Stamenova S; Caiazzo G; d'Ambrosio A; Sacco R; Docimo R; Esposito S; Cirillo M; Esposito F; Bonavita S; Tedeschi G; Gallo A
    Brain Imaging Behav; 2018 Feb; 12(1):20-28. PubMed ID: 28083844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy.
    Benedict RH; Ramasamy D; Munschauer F; Weinstock-Guttman B; Zivadinov R
    J Neurol Neurosurg Psychiatry; 2009 Feb; 80(2):201-6. PubMed ID: 18829629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis.
    Hyun JW; Park G; Kwak K; Jo HJ; Joung A; Kim JH; Lee SH; Kim S; Lee JM; Kim SH; Kim HJ
    Eur J Neurol; 2017 Feb; 24(2):437-445. PubMed ID: 28009104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcortical gray matter atrophy is associated with cognitive deficit in multiple sclerosis but not in systemic lupus erythematosus patients.
    Kalinowska-Łyszczarz A; Pawlak MA; Pietrzak A; Pawlak-Buś K; Leszczyński P; Puszczewicz M; Majewski D; Paprzycki W; Kozubski W; Michalak S
    Lupus; 2018 Apr; 27(4):610-620. PubMed ID: 28992796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated segmentation of cerebral deep gray matter from MRI scans: effect of field strength on sensitivity and reliability.
    Chu R; Hurwitz S; Tauhid S; Bakshi R
    BMC Neurol; 2017 Sep; 17(1):172. PubMed ID: 28874119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between Deep Gray Matter Changes and Neurocognitive Function in Mild Cognitive Impairment and Alzheimer's Disease: A Tensor-Based Morphometric MRI Study.
    Tuokkola T; Karrasch M; Koikkalainen J; Parkkola R; Lötjönen J; Löyttyniemi E; Hurme S; Rinne JO
    Dement Geriatr Cogn Disord; 2019; 48(1-2):68-78. PubMed ID: 31514198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of 7 T MRI to assess atrophy of the subcortical deep gray matter in relapsing-remitting multiple sclerosis.
    Callen AM; Zurawski J; Chu R; Tie Y; Tauhid S; Quattrucci M; Healy BC; Bakshi R
    J Neurol; 2024 Oct; 271(10):6935-6943. PubMed ID: 39240345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebellar contribution to motor and cognitive performance in multiple sclerosis: An MRI sub-regional volumetric analysis.
    D'Ambrosio A; Pagani E; Riccitelli GC; Colombo B; Rodegher M; Falini A; Comi G; Filippi M; Rocca MA
    Mult Scler; 2017 Aug; 23(9):1194-1203. PubMed ID: 27760859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
    Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
    Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep grey matter MRI abnormalities and cognitive function in relapsing-remitting multiple sclerosis.
    Debernard L; Melzer TR; Alla S; Eagle J; Van Stockum S; Graham C; Osborne JR; Dalrymple-Alford JC; Miller DH; Mason DF
    Psychiatry Res; 2015 Dec; 234(3):352-61. PubMed ID: 26602610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of Gray and White Matter Abnormalities to Cognitive Impairment in Multiple Sclerosis.
    Zhang X; Zhang F; Huang D; Wu L; Ma L; Liu H; Zhao Y; Yu S; Shi J
    Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28035997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalamus volume change and cognitive impairment in early relapsing-remitting multiple sclerosis patients.
    Rojas JI; Murphy G; Sanchez F; Patrucco L; Fernandez MC; Miguez J; Funes J; Golimstok A; Cristiano E
    Neuroradiol J; 2018 Aug; 31(4):350-355. PubMed ID: 29869576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volume loss in the deep gray matter and thalamic subnuclei: a longitudinal study on disability progression in multiple sclerosis.
    Magon S; Tsagkas C; Gaetano L; Patel R; Naegelin Y; Amann M; Parmar K; Papadopoulou A; Wuerfel J; Stippich C; Kappos L; Chakravarty MM; Sprenger T
    J Neurol; 2020 May; 267(5):1536-1546. PubMed ID: 32040710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased mean R2* in the deep gray matter of multiple sclerosis patients: Have we been measuring atrophy?
    Hernández-Torres E; Wiggermann V; Machan L; Sadovnick AD; Li DKB; Traboulsee A; Hametner S; Rauscher A
    J Magn Reson Imaging; 2019 Jul; 50(1):201-208. PubMed ID: 30511803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Susceptibility Mapping Values Quantification in Deep Gray Matter Structures for Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis.
    Mohammadi S; Ghaderi S; Fatehi F
    Brain Behav; 2024 Oct; 14(10):e70093. PubMed ID: 39415615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis.
    Gaetano L; Häring DA; Radue EW; Mueller-Lenke N; Thakur A; Tomic D; Kappos L; Sprenger T
    Neurology; 2018 Apr; 90(15):e1324-e1332. PubMed ID: 29540589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staging of cortical and deep grey matter functional connectivity changes in multiple sclerosis.
    Meijer KA; Eijlers AJC; Geurts JJG; Schoonheim MM
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):205-210. PubMed ID: 28986469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
    Sacco R; Bisecco A; Corbo D; Della Corte M; d'Ambrosio A; Docimo R; Gallo A; Esposito F; Esposito S; Cirillo M; Lavorgna L; Tedeschi G; Bonavita S
    J Neurol; 2015 Jul; 262(7):1691-7. PubMed ID: 25957638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.